Nik Morton
Executive Vice President, Chief Strategy and Transformation Officer
Nik Morton, Executive Vice President, Chief Strategy and Transformation Officer, at Worldwide Clinical Trials, has successfully developed new capabilities, built high-performing teams, and driven significant operational performance and customer satisfaction improvements through infrastructure, process, and technology changes. His deep career experience includes servicing biotech and pharmaceutical customers with exceptionally broad cross-functional and multi-geographical management responsibilities. Most recently Nik served as CEO of Catalyst Clinical Research, a specialized oncology contract research organization (CRO), known for its expertise in early phase oncology trials, strong biometrics, and functional service provider (FSP) capabilities.
Ask Nik a question
Submit an RFP. Ask a Question
Prior to joining Catalyst, Nik held a series of key leadership roles at PPD across different operational and corporate functions. He led global project management, site and patient access, and biometrics functions. Nik’s data science and automation expertise aligned with these earlier roles, leading him to launch a new business unit focused on digitally enabled and decentralized clinical trial capabilities, demonstrating his innovative entrepreneurial and transformational leadership. This initiative introduced a different clinical trial paradigm service model that leveraged cutting-edge digital tools and remote technologies to enhance patient access, streamline trial execution, and open new revenue streams in a rapidly evolving landscape.
Nik earned his Master of Science in Medical Statistics from the University of Leicester and a Bachelor of Statistics from the University of Glasgow.
